Evidence map›Paper›PMID 27307797›Full record

ArticleThe EPMA journal2016

Multiple sclerosis and primary vascular dysregulation (Flammer syndrome).

Katarzyna Konieczka, Simone Koch, Tatjana Binggeli, Andreas Schoetzau, Juerg Kesselring

Abstract read
In one paragraph

Article in The EPMA journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katarzyna KonieczkaDepartment of Ophthalmology, University of Basel, Mittlere Strasse 91, CH-4031 Basel, Switzerland.
Simone KochDepartment of Ophthalmology, University of Basel, Mittlere Strasse 91, CH-4031 Basel, Switzerland.
Tatjana BinggeliDepartment of Ophthalmology, University of Basel, Mittlere Strasse 91, CH-4031 Basel, Switzerland.
Andreas SchoetzauDepartment of Ophthalmology, University of Basel, Mittlere Strasse 91, CH-4031 Basel, Switzerland.
Juerg KesselringDepartment of Neurology and Neurorehabilitation, Rehabilitation Centre Valens, Valens, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS of still unknown aetiology. Flammer syndrome (FS) encompasses a set of symptoms and signs that are primarily but not solely related to the dysregulation of blood vessels. The purpose of the present study was to determine whether FS symptoms occur more often in MS patients than in controls.

methodsFifty-eight MS patients and 259 controls answered a questionnaire covering 15 symptoms and signs of FS.

resultsSix of the 15 symptoms and signs of FS (dizziness, low body mass index, cold hands and/or feet, tendency toward perfectionism, reduced thirst, feeling cold) were found significantly more often in MS patients than in controls. Seven additional symptoms and signs (tinnitus, headaches, increased pain sensation, long sleep-onset time, migraines, increased response to certain drugs, low blood pressure) also occurred more often in MS patients, but the difference in frequency was not statistically significant. One sign (reversible skin blotches) was found less often in MS patients, but the difference in frequency was not statistically significant. One symptom (increased smell perception) was found significantly less often in MS patients.

conclusionsMS patients suffer significantly more often from FS symptoms and signs than controls. The reason for this association between MS and FS and the potential implications of this association still need to be determined.

Indexed as

Flammer syndrome (FS)Multiple sclerosis (MS)Personalized medicinePredictive diagnosticsPrimary vascular dysregulation (PVD)QuestionnaireTargeted prevention

Identifiers

PMID27307797
PMCPMC4908696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.